Nine Masts Capital »

Nautilus Biotechnology shares owned by Nine Masts Capital

Quarter-by-quarter ownership of Nautilus Biotechnology (NAUT) shares owned by Nine Masts Capital from 13F filings

Historical chart of Nine Masts Capital investment in Nautilus Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Nautilus Biotechnology held by Nine Masts Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nautilus Biotechnology by Nine Masts Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $40k 10k 3.88

More positions owned by Nine Masts Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Alphabet Cap Stk Cl C (GOOG)
Warner Bros Discovery Com Ser A (WBD)
Silicon Laboratories (SLAB)
Hdfc Bank Sponsored Ads (HDB)
Electronic Arts (EA)
Fox Corp Cl B Com (FOX)
Norfolk Southern (NSC)
Clearwater Analytics Hldgs I Cl A (CWAN)
Webster Financial Corporation (WBS)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Hologic
Nio Note 4.625%10/1 (Principal)
Ase Technology Hldg Sponsored Ads (ASX)

View all positions for Nine Masts Capital

Top funds holding Nautilus Biotechnology

AH Capital Management
Perceptive Advisors
Cercano Management
Madrona Venture Group
Vanguard Group
Vanguard Capital Management
Hartland & Co
Comprehensive Financial Management
Amazon
Millennium Management
Clarius
_Sentinel Trust Company, LBA______________
Acadian Asset Management
Tikvah Management
Geode Capital Management

View all funds holding Nautilus Biotechnology